Main menu


You are here

Home

Treatments

Covid-19 antibody levels jump among elderly after autumn booster--British study

Wed, 2023-01-18 09:19 — mike kraft
Covid-19 antibody levels jump among elderly after autumn booster The 35-49 age group now has the lowest estimated level of antibodies. Ian Jones, PA AOL

...

Some 96.3% of people aged 80 and over in England were likely to have antibodies at the start of December 2022, up from 89.2% in early September.

For 75 to 79-year-olds, the proportion stands at 95.8%, up from 87.4%.   ...

The figures are “likely a result of the vaccination booster campaign”, according to the Office for National Statistics (ONS), which has published the data.

...

Country / Region Tags: 
Europe
Global
UK - London
United Kingdom
General Topic Tags: 
COVID-19
Symptoms
Boosters
Treatments
Data
Demographics
Disease
Disease Prevention
Government
Health
Mutations
Pandemics
Public Health
Research
Vaccinations
Problem, Solution, SitRep, or ?: 
Analysis
Situation Report

More Americans than ever putting off medical care due to cost: Gallup poll

Tue, 2023-01-17 10:39 — mike kraft
More Americans than ever putting off medical care due to cost: Gallup The percentage of Americans who postponed medical care payments due to cost has grown in the past year, according to a new Gallup poll.  The poll, published on Tuesday, found that 38 percent of res… ooshin The Hill
Country / Region Tags: 
United States
General Topic Tags: 
Treatments
Data
Demographics
Disease
Disease Prevention
Health
Hospitals
Medical Testing
Public Attitudes
Public Health
Research
Social behavior
Economics
Problem, Solution, SitRep, or ?: 
Situation Report

CDC identifies possible safety issue with Pfizer’s updated Covid-19 vaccine for seniors but says people should still get boosted

Fri, 2023-01-13 18:59 — mike kraft
CDC identifies possible safety issue with Pfizer's updated Covid-19 vaccine but says people should still get boosted | CNN The US Centers for Disease Control and Prevention said Friday that there is a possible safety issue with the bivalent Covid-19 vaccine made by Pfizer and BioNTech but that it is unlikely to represent a true risk. The agency said it continues to recommend that people stay up-to-date with Covid-19 vaccines. Brenda Goodman CNN

 

Country / Region Tags: 
Global
United States
General Topic Tags: 
COVID-19
Boosters
Treatments
Disease
Government
Health
Mutations
Pandemics
Public Health
Research
Vaccinations
Problem, Solution, SitRep, or ?: 
Situation Report

New Utah study affirms COVID vaccine is safe for kids

Fri, 2023-01-13 10:29 — mike kraft
New Utah study affirms COVID vaccine is safe for kids The study, co-authored by a doctor at Primary Children's Hospital, looked at 185 kids who suffered from MIS-C. Erin Alberty Axios

A new Utah-led study shows the COVID-19 vaccine didn't trigger dangerous responses in children who previously had a severe reaction to the virus itself.

...

Country / Region Tags: 
Global
United States
General Topic Tags: 
COVID-19
Treatments
Contagion
Data
Demographics
Disease
Disease Prevention
Health
Mutations
Pandemics
Public Health
Research
Vaccinations
Problem, Solution, SitRep, or ?: 
Analysis
Situation Report

Convalescent plasma works for immune-compromised Covid-19 patients, but it can be hard to find --study

Thu, 2023-01-12 19:02 — mike kraft
Study shows convalescent plasma works for immune-compromised Covid-19 patients, but it can be hard to find | CNN Convalescent plasma -- a once-celebrated treatment for Covid-19 that has largely fallen out of favor -- does work well for people who are immune-compromised, according to a study published Thursday. Elizabeth Cohen CNN

...

Country / Region Tags: 
Global
United States
General Topic Tags: 
COVID-19
Treatments
Disease
Government
Health
Hospitals
Mutations
Pandemics
Public Health
Research
Problem, Solution, SitRep, or ?: 
Analysis
Situation Report

Paying people to take COVID vaccine worked well, European study

Thu, 2023-01-12 18:56 — mike kraft
Paying people to take COVID vaccine worked well, study finds Paying people to take a first COVID-19 vaccine dose didn't lower the likelihood of seeking the second or third dose or of other positive health behaviors. CIDRAP

A study finds that paying people to take a first dose of a COVID-19 vaccine didn't lower the likelihood of seeking the second or third dose or of other positive health behaviors and didn't erode morals, sense of civic duty, or feelings of self-determination.

Country / Region Tags: 
Europe
Global
Sweden
General Topic Tags: 
COVID-19
Treatments
Disease
Disease Prevention
Government
Health
Mutations
Pandemics
Public Attitudes
Public Health
Research
Social behavior
Vaccinations
Problem, Solution, SitRep, or ?: 
Analysis
Situation Report

Reports very rare of Serious Adverse Events After Updated COVID-19 Booster Shots for Children--study

Thu, 2023-01-12 18:01 — mike kraft
CDC Study: Reports of Serious Adverse Events After Updated COVID-19 Booster Shot Among Children Rare The study said that the preliminary safety findings for the updated COVID-19 booster shot were ‘reassuring.’ Cecelia Smith-Schoenwalder US News & World Report
Country / Region Tags: 
United States
General Topic Tags: 
COVID-19
Boosters
Treatments
Data
Demographics
Disease
Disease Prevention
Government
Health
Mutations
Pandemics
Public Health
Research
Vaccinations
Problem, Solution, SitRep, or ?: 
Analysis

Mpox has faded in the US. Who deserves the credit?

Wed, 2023-01-11 19:37 — mike kraft
Mpox has faded in the US. Who deserves the credit? NEW YORK (AP) — Less than six months ago, mpox was an exploding health crisis. What had been an obscure disease from Africa was ripping through European and U.S. gay communities. Precious doses of an unproven vaccine were in short supply. AP NEWS

...

So who deserves the credit? It’s an unsettled question, but experts cite a combination of factors.

Country / Region Tags: 
United States
General Topic Tags: 
Mpox
Treatments
Disease
Disease Prevention
Government
Health
Medical Personnel
Public Attitudes
Public Health
Research
Social behavior
Social distancing
Problem, Solution, SitRep, or ?: 
Analysis

Bivalent COVID vaccines: how they're stacking up against omicron

Wed, 2023-01-11 19:30 — mike kraft
Bivalent COVID vaccines have now been in use for a few months—here's how they're stacking up against omicron Vaccines have played a major role in mitigating the harms of the COVID pandemic since their rollout began just over two years ago. They're estimated to have saved tens of millions of lives across the ... Neil Mabbott

...

Country / Region Tags: 
Global
United States
General Topic Tags: 
COVID-19
Boosters
Treatments
Contagion
Disease
Disease Prevention
Government
Health
Medical Testing
Mutations
Pandemics
Public Health
Research
Vaccinations
Problem, Solution, SitRep, or ?: 
Analysis
Situation Report

U.S. extends public health emergency status for COVID

Wed, 2023-01-11 17:11 — mike kraft
U.S. extends public health emergency status for COVID The U.S. health department on Wednesday extended the COVID-19 pandemic's status as a public health emergency, allowing millions of Americans to continue receiving free tests, vaccines and treatments. Ahmed Aboulenein Reuters

...

Country / Region Tags: 
United States
General Topic Tags: 
COVID-19
Boosters
Treatments
Contagion
Disease
Disease Prevention
Government
Health
Masks
Medical Testing
Mutations
Pandemics
Policy
Public Health
Science
Vaccinations
Problem, Solution, SitRep, or ?: 
Situation Report

Pages

Subscribe to Treatments
howdy folks
Page loaded in 0.519 seconds.